Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05770063

Enrollment

Registered

2023-03-15

Start date

2023-04-15

Completion date

2023-08-30

Last updated

2023-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amino Acid Deficiency, Lung Cancer, Malnutrition

Brief summary

To investigate whether compound amino acid supplementation can further promote protein synthesis and improve nutritional status for lung cancer patients.

Interventions

DIETARY_SUPPLEMENTamino acid tablet

multiple essential amino acids supplements

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* NRS2002 \>=3 scores * lung cancer patients * low albumin or hemoglobin * informed consent

Exclusion criteria

* Acute and critical patients; * Severe liver and kidney dysfunction; * Patients with gastrointestinal bleeding or intestinal obstruction; * Pregnant women, lactating women, people with mental illness, and people without independent behavior ability.

Design outcomes

Primary

Measure	Time frame
Concentration of albumin	after 42 days after the intervention

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026